Context Therapeutics, Inc. (CNTX)
0.1935
+0.01
(+2.98%)
USD |
NASDAQ |
Nov 06, 16:00
0.1942
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Free Cash Flow : -40.53M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -40.53M |
| March 31, 2026 | -34.82M |
| December 31, 2025 | -28.42M |
| September 30, 2025 | -22.38M |
| June 30, 2025 | -32.49M |
| March 31, 2025 | -30.02M |
| December 31, 2024 | -29.31M |
| September 30, 2024 | -31.63M |
| June 30, 2024 | -18.40M |
| March 31, 2024 | -19.68M |
| Date | Value |
|---|---|
| December 31, 2023 | -21.05M |
| September 30, 2023 | -18.25M |
| June 30, 2023 | -17.78M |
| March 31, 2023 | -15.96M |
| December 31, 2022 | -14.09M |
| September 30, 2022 | -14.62M |
| June 30, 2022 | -11.67M |
| March 31, 2022 | -10.94M |
| December 31, 2021 | -8.800M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EyePoint, Inc. | -271.28M |
| Neumora Therapeutics, Inc. | -180.96M |
| LENZ Therapeutics, Inc. | -127.70M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 194.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.020M |
| Cash from Investing (Quarterly) | -4.518M |
| Free Cash Flow Per Share (Quarterly) | -0.1212 |
| Free Cash Flow to Equity (Quarterly) | -11.50M |
| Free Cash Flow to Firm (Quarterly) | -11.54M |
| Free Cash Flow Yield | -222.0% |